Delivery Order SPE2DB20D3101-SPE2DB25FRUR6
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Azithromycin 500 mg tablets (30-count packaging) with a ceiling value of $9,828.00. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is set to be completed by July 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Azithromycin 500 mg tablets in quantities of 30, with a contract ceiling value of $1,430.45. This is a firm fixed-price delivery order under a non-competitive, non-set-aside arrangement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 19, 2025. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a $2,604.70 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Azithromycin 500 mg tablets in quantities of 30 units. This contract utilizes a firm fixed price structure with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by September 18, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Azithromycin 500 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $16,453.75 and an ultimate completion date of July 25, 2025. The contract was competitively awarded with no set-aside designation, and the place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Azithromycin 500 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $4,486.90 and a completion date of August 1, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Azithromycin 250 mg tablets in quantities of 30 units. This delivery order, valued at $1,255.04 with a firm fixed price structure, represents a non-competitive set-aside award and is scheduled for completion by September 17, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Azithromycin 500 mg tablets (30-count units) with a ceiling value of $22,012.80. This is a firm fixed-price delivery order with an ultimate completion date of September 8, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a $2,279.96 delivery order to AmerisourceBergen Drug Corp for Azithromycin 250 mg tablets on April 24, 2025, with completion scheduled for April 25, 2025. This order represents a competitive, non-set-aside contract utilizing firm fixed pricing under a delivery order vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical procurement needs across military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $73,152.00 to AmerisourceBergen Drug Corp for the supply of Azithromycin 500 mg tablets (30-count units) on September 5, 2025, with an ultimate completion date of September 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Azithromycin 500 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $1,979.82 and an ultimate completion date of August 6, 2025. The contract was competitively awarded with no set-aside designation, and performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRUR6Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Azithromycin 500 mg tablets in quantities of 30 units under a firm fixed-price contract valued at $4,548.82. The contract is not set-aside and represents a competitive award to the pharmaceutical distributor for delivery to its facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 9, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical supplier to federal military and veteran healthcare systems through its comprehensive IDC vehicle, which enables the company to provide a broad spectrum of medications, vaccines, and medical supplies to support global military healthcare programs. The company maintains significant federal contracting capacity through the DLA's Pharmaceutical Prime Vendor Global Program, demonstrating its capability to fulfill competitive pharmaceutical procurement requirements across multiple therapeutic domains for the Defense Health Agency and other federal healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 9/8/25 |